glp-1 updates Clinical Practice Updates: December 2025 Key Developments What's next for GLP-1 innovation:

I lost 10 lbs., in three weeks by eating fruit for breakfast, 4 oz of meat, a bowl of veggies for lunch, and 4 oz of fish and veggies for dinner

Endocrinologist Daniel Drucker says that the trials were well-done but the results are a setback for the field. Novo Nordisk confirmed in a statement to Scientific American that the company is ending its semaglutide trials on Alzheimers, including tests involving the injectable version of the drug

Metabolism of Purine Bases, Nucleosides and Alkaloids in Theobromine-Forming Theobroma Cacao Leaves

Mol Pain 14:1744806918767697 Aurora SK, Brin MF (2017) Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies